Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Diego Francisco Benítez-Chao
 -- 2480 2023-09-07 00:38:42 |
2 only format change
Alfred Zheng
 Meta information modification 2480 2023-09-07 04:19:15 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Garza-Juárez, A.; Pérez-Carrillo, E.; Arredondo-Espinoza, E.U.; Islas, J.F.; Benítez-Chao, D.F.; Escamilla-García, E. Biological Potential of Nutraceuticals to Preventing Noncommunicable Diseases. Encyclopedia. Available online: https://encyclopedia.pub/entry/48894 (accessed on 08 September 2024).
Garza-Juárez A, Pérez-Carrillo E, Arredondo-Espinoza EU, Islas JF, Benítez-Chao DF, Escamilla-García E. Biological Potential of Nutraceuticals to Preventing Noncommunicable Diseases. Encyclopedia. Available at: https://encyclopedia.pub/entry/48894. Accessed September 08, 2024.
Garza-Juárez, Aurora, Esther Pérez-Carrillo, Eder Ubaldo Arredondo-Espinoza, Jose Francisco Islas, Diego Francisco Benítez-Chao, Erandi Escamilla-García. "Biological Potential of Nutraceuticals to Preventing Noncommunicable Diseases" Encyclopedia, https://encyclopedia.pub/entry/48894 (accessed September 08, 2024).
Garza-Juárez, A., Pérez-Carrillo, E., Arredondo-Espinoza, E.U., Islas, J.F., Benítez-Chao, D.F., & Escamilla-García, E. (2023, September 07). Biological Potential of Nutraceuticals to Preventing Noncommunicable Diseases. In Encyclopedia. https://encyclopedia.pub/entry/48894
Garza-Juárez, Aurora, et al. "Biological Potential of Nutraceuticals to Preventing Noncommunicable Diseases." Encyclopedia. Web. 07 September, 2023.
Biological Potential of Nutraceuticals to Preventing Noncommunicable Diseases
Edit
This entry is adapted from the peer-reviewed paper 10.3390/foods12173262

Food plays a fundamental role in the maintenance of health. Particularly, the lack of a good diet leads to the development of several noncommunicable diseases (NCDs), such as cardio-metabolic dysfunction, overweight, obesity, diabetes, cancer, diabetes, etc. It is important to acquire information about natural food sources and food supplements, as they are a source of beneficial nutrients that sustain health.

bioactive compounds health noncommunicable diseases

1. Introduction

Ancient Greek and Asian societies postulated the concept that some foods could be injurious, whereas others have restorative capabilities. Even Hippocrates stressed that food could be our first medicine by eating a balanced diet to preserve health [1]. Homeostasis can be referred to as an essential balance among the vital functions of the body and mind [2], a state typically achieved by having a healthy lifestyle which encompasses eating a balanced diet, performing regular physical activity, and getting enough rest [3][4].
Food plays a fundamental role in the maintenance of health [5]. Particularly, the lack of a good diet leads to the development of several noncommunicable diseases (NCDs), such as cardio-metabolic dysfunction, overweight, obesity, diabetes, cancer, diabetes, etc. [6][7]. In 2004, the World Health Organization (WHO) established a strategy on diet, health, and physical activity to be implemented around the world [8], with the aim of improving global health through educational programs focused on the correct consumption of food. Among the distinct types of foods, functional foods are widely accepted as part of the human diet due to their flavors and nutritional properties, including bioactive components and essential oils [9], which are collectively regarded as nutraceuticals [10][11].

2. Nutraceuticals: Classification and Biological Potential

The term “nutraceutical” was coined into existence in 1989 by Dr. Stephen DeFelice from the word nutrition and pharmaceutical, and it refers to the food or part of food that provides health benefits, including prevention and treatment of diseases beyond its nutritional functions [12]—how a biologically or pharmacologically active substance (drug) alters a living organism, influencing the synthesis of proteins and the genetic material (DNA), translates into the mechanism of action [13]. So, what is the distinction between a drug and a nutraceutical? The primary objective of a drug is to address conditions with curative possibilities, and its fundamental origin is from natural medicinal herbs, manufactured by chemical, computer-aided drug design techniques or biological origins [14].
Sometimes, a drug acts on the intended targets in testing and design, contemplating toxicity, with additional benefits or side effects derived from binding to unproven targets [15]. “Nutraceuticals” are assigned to those bioactive compounds having a physiological effect intended to prevent and treat diseases or disorders other than deficiency conditions [16]. Salicylic acid, a compound originating in the white willow bark, is one of the most renowned, having been employed by the Phoenicians and ancient Greeks as an antiseptic and analgesic two millennia ago [17]. Since then, various properties of salicylic acid have been discovered, benefiting health as an antipyretic, anti-inflammatory, antibacterial, and anti-acne agent, including keratolytic and hemolytic properties that allow exfoliation of the skin where an accumulation of necrotic tissue is abundant, stimulating the regeneration of keratinocytes of the epidermis as the uppermost layer of the skin [17][18].
The biological contribution of nutraceuticals is extensive and includes the prevention or treatment of diseases in humans and animals and multiple benefits that help strengthen health. Therefore, nutraceuticals can be studied or classified from different angles to better understand their functioning in the body and the source that contains them. One classification includes three physiological stages that may limit its oral bioavailability [19]. Namely, (I) bio-accessibility (release, solubilization, and interactions), (II) absorption (mucous layer, close-junction transport, bilayer permeability, active transporters, and affluent transporters), and (III) transformation (degradation and metabolism).
There are other reports published [20][21], in which the authors present a classification of nutraceuticals from different perspectives:
(a) The source of origin: plants (garlic, aloe vera, ginger, containing organic acids, salts, tannins, and hormones), animals (oils and proteins), microorganisms (proteins, amino acids, vitamins, probiotics, prebiotics, dietary supplements, and peptides). (b) Traditional nutraceuticals: fruits (phenolic compounds, tannins, vitamins, and terpenes), vegetables (minerals, vitamins, organic acids, carotenes, and terpenes). (c) Non-traditional nutraceuticals: fortified foods (juices, cereals, vitamin additives, and minerals), originated by biotechnological processes (bread; alcoholic beverages such as beer, wine, pulque, tequila, mezcal, and apple or cane vinegar; production of amino acids and other bioceutical derivatives), or recombinant genetic engineering (production of enzymes and obtaining new nutraceutical pathways). (d) Chemical nature: herbs or spices, nutrients, phytochemicals, enzymes, terpenes (vegetables, fruits, and citrus fruits), phenolic compounds (coffee, spices, seeds, pulp and bunches of grapes, cocoa, red fruits, tea leaves, mango, banana, and spinach), and minerals (legumes, vegetables, some fruits, and spices). Nutraceuticals such as omega-3 are reported to have more than one mechanism of action. (e) The mechanism of action: their principle is to maintain and improve the physiological properties of an organism, and they are used in specific medical conditions with varied effects such as anti-inflammatory (ginger and orange peel extract), antimicrobial, osteoprotective, anti-glycemic/antihypertensive (blueberries), antioxidant (broccoli extracts), and anti-hypercholesterolemic (as the β-glucan contained in oats) [22]; however, in some cases their toxicity, and synergy, or competition are still unknown. This fatty acid has an anti-inflammatory, anticoagulant, and antithrombotic activity [23]. It is naturally in oily fish, shellfish, grains such as soy, canola, and flaxseed, walnut, to name a few.
Some widely studied bioactive compounds that have been shown to have anti-inflammatory, neuroprotective, and antioxidant activity, or as cofactors in important metabolic pathways. Here, the information is directed to those nutraceutical compounds that have a biological contribution to health, to the foods that contain them, and to therapeutic use, helping in the prevention or treatment of diseases, according to reported data.

2.1. Vitamins

Vitamin C. This vitamin represents a redox system comprising 2 L-isomers: ascorbic acid (vitamin C) in the reduced state and dehydro-ascorbic acid (DHA) in the oxidized form. Most of its functionality in the human body is related to its role as an electron donor; hence, it is active and is stable in tissues. It is used as a cofactor or antioxidant; it is oxidized and becomes unstable [24]. Vitamin C intake as part of one’s diet has a positive effect on many illnesses such as the common cold, cardiovascular illnesses, and certain types of cancer, in addition to age-related macular degeneration, cataracts, diabetes, rheumatoid arthritis, and even has a protective effect on periodontal tissues, reducing severe cases of periodontitis [25]. For many biosynthetic and gene regulatory enzymes, this vitamin plays a crucial role in immunomodulation because it stimulates neutrophil migration to the site of infection and enhances phagocytosis and oxidant generation [24][26].
In contrast with many other vitamins, the content of vitamin C in various foods is high (10–100 mg/100 g), in some cases, reaching units of grams per 100 g of fresh weight. Most people get much of their daily vitamin C intake through regular fresh fruits and fruit juices, as illustrated in Figure 1 [24].
Foods 12 03262 g002
Figure 1. Chemical formulas for nutraceutical compounds such as Vitamins (Foods 12 03262 i001), Minerals (Foods 12 03262 i002), and Plants (Foods 12 03262 i003) lie to dietary source.
Vitamin D: The classical function, which involves mineral balance and skeletal maintenance, has been known for many years. With the discovery of vitamin receptors in various tissues, several other biological functions of this vitamin are recognized today. Its activity is explored in several human disorders such as cancer, diabetes, hypertension, cardiovascular disease, and immunological and dermatological alterations. Vitamin D occurs in two primary forms: vitamin D2 or ergocalciferol synthesized by ultraviolet B (UV-B) irradiation of the ergosterol contained in yeast, fungi, and a few natural foods, fortified food, and supplements. Vitamin D3 or cholecalciferol is obtained through a photochemical reaction in the skin and diet via the intake of animal-based foods (cod liver oils and oily fish) [27].
Vitamin E (α-tocopherol): It has been recognized as an essential lipophilic antioxidant in humans protecting lipoproteins, polyunsaturated fatty acid (PUFA), and cellular and intracellular membranes from damage for a long time [28]. One of the more interesting effects of this nutraceutical is its use in the treatment of Alzheimer’s disease. Vitamin E’s tocopherol and tocotrienol isoforms have multiple properties, including potent antioxidant and anti-inflammatory characteristics and influences on immune function, cellular signaling, and lowering cholesterol. In general, nuts and vegetable oils are rich in tocopherols, whereas barley, oat, palm oil, rice bran, rye, and wheat germ are rich in tocotrienol. In addition, natural sources of both vitamin E isomers are also in other daily foods, i.e., fruits, seafood, cheese, and eggs.
Retinoic acid (RA): RA is a metabolite made from vitamin A and is the driving force behind many of vitamin A’s characteristics. It has been documented that its three isomers, 9-cis, 13-cis, and all-trans RA, have diverse capabilities to modulate cellular growth and differentiation. Other abilities of these isomers to regulate cellular growth and differentiation may be attributable to differences in affinities to their nuclear receptors [29].

2.2. Minerals

Selenium: It is most easily absorbed in organic compounds and in the presence of vitamins A, D, and E. The primary sources of selenium in the diet are foods such as cereals, meat, dairy products, seafood, and nuts (Figure 1). Rich sources of selenium are sea salt, eggs (only in the case of Se-yeast supplementation of feed), giblets, yeast (containing selenium), bread, mushrooms, garlic, asparagus, and kohlrabi (enriched with this element) [30].
Zinc: Among the various food products, red meat, some seafoods, dairy products, nuts, seeds, dried legumes, and whole-grain cereals are considered good dietary sources of zinc. It is an essential trace element or a micronutrient essential for the growth and reproduction of all higher plants, animals, and humans. It is vital for the functionality of over 300 enzymes, stabilization of DNA, and gene expression. In addition, it plays a key role during physiological development and fulfils an immune function. The properties of zinc, such as toxicity, teratogenicity, carcinogenicity, and immunological, are relevant to cancer prevention [31].

2.3. Plants

Silymarin: This compound is derived from the leaves of milk thistle (Silybum marianum), Figure 1. The main bioactive components of silymarin are flavonolignans: silybin, silicristin, silidianin, isosilibin, dehydrosilibin, and some flavonoids, taxifolin [3]. The mixture of silybin A and silybin B (1:1) is the main active ingredient (approximately 50%) of silymarin. Silymarin flavonolignans are agents that typically possess antioxidant, anti-inflammatory, immunomodulatory, and hepatoprotective properties [32][33]. Consequently, silymarin has been suggested to be incorporated as a complementary treatment for inflammatory liver diseases including cirrhosis, hepatitis, alcoholic fatty liver disease, and non-alcoholic fatty liver disease (NAFLD) [32]. It is also known as a neuroprotective agent against many neurological disorders including Alzheimer’s and Parkinson’s diseases and cerebral ischemia. Recent studies reported its antiviral activity against various viruses, including flaviviruses (from hepatitis C and dengue), togavirus (i.e., Chikungunya and Mayaro), influenza virus, human immunodeficiency virus, and that of hepatitis B [33].
Epicatechin: Epicatechin is a flavonoid polyphenol from the flavanol group; it is a natural component in cocoa and its products, found in dark chocolate and green tea. Scientific evidence has shown that populations that consume substantial amounts of cocoa daily (Figure 1) have low blood pressure and a significantly lower incidence of cardiovascular disease [34][35]. The literature proposes that one of the main beneficial effects of epicatechin is achieved through its ability to remove reactive oxygen species (ROS) directly or indirectly by reacting chemically with ROS or by modulating pathways that regulate ROS-scavenging compounds and enzymes, respectively [35][36].
Epicatechin can also combat diseases such as diabetes mellitus and cancer with an inflammatory component. Epicatechin interferes with cancer signaling, making cells more susceptible to apoptosis, an effect that could be used to sensitize cancer cells to radiation or chemotherapy treatment. In addition, epicatechin appears to inhibit the proliferation of Hodgkin lymphoma cells and Jurkat T cells by inhibiting the binding of NF-κB to DNA in these cells [34][35].
Curcumin: A yellow pigment is the main component of turmeric, the rhizome of Curcuma longa XU [37]. At the molecular level, it exhibits anti-inflammatory activity through the suppression of various cellular signaling pathways, including NF-κB, STAT3, Nrf2, ROS, and COX-2. Numerous studies have indicated that curcumin is a very potent antimicrobial agent and is active against various chronic diseases, including multiple types of cancers, diabetes, obesity, in addition to cardiovascular, lung, neurological, and autoimmune diseases [38][39].
Resveratrol: 3,5,4′-trihydroxystilbene is a naturally occurring phytochemical. Its trans-isomer glycosylated form is found in plants as Polygonum cuspidatum, fruits including grapes and berries, peanuts, and red wine, Figure 1. Its use as a nutraceutical has been studied in both animal and human models, including clinical trials, in people with obesity, metabolic syndrome, heart disease, and cancer, among others; however, to date, there are no specific recommendations on the dose and duration of supplementation [32][40]. Resveratrol is a compound with antioxidative properties and is considered for treatment of neurodegenerative diseases characterized by elevated levels of oxidative damage in, for example, Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis [41].
Previously mentioned, resveratrol may improve or assist in the treatment of metabolic syndrome. There is scientific evidence of the anti-inflammatory effect of resveratrol. This compound inhibits the production of pro-inflammatory cytokines and the activity of cyclo-oxygenases (COX-1 and COX-2) and inducible nitric oxide synthase [40][42].
Oroxylin A: This is a natural flavonoid isolated from Scutellaria baicalensis and widely used in traditional oriental medicine. It exhibits several beneficial effects, including anti-inflammatory, anti-cancer, antiviral, and antibacterial activity [43][44][45][46][47]. Oroxylin A has exerted inhibition of cell growth and induces apoptosis in various cancer cells. Oroxylin A can help treat colitis, allergy, and liver damage; these anti-inflammatory effects are attributed to the regulation of the NF-κB regulatory pathway with the consequent recruitment of immune cells and release of cytokines [44][47][48].
Quercetin: Another flavonoid present in fruits, vegetables, tea, and red wine (Figure 1), quercetin has shown beneficial health effects as an antioxidant and having anti-inflammatory, anti-allergic, and anti-thrombotic effects, with vasodilatory actions [37][49]. Quercetin reduced systolic blood pressure and plasma-oxidized LDL concentrations, evidencing that quercetin may safely protect against cardiovascular disease [50]. Due to its biological properties, quercetin was tested for treatment of neurodegenerative diseases, by evaluating the effect on signaling events of dopaminergic neuronal models and further testing its efficacy in the MitoPark transgenic mouse model of Parkinson’s disease [51].
Apigenin: It is abundant in fruits and vegetables; it has antioxidants, anti-inflammatory, and anti-cancer effects. It exerts a protective effect against oxidative stress-related diseases, including metabolic disorders, obesity, neurodegenerative diseases, and cancer [35][52][53][54]. Obesity represents a significant health issue; the administration of apigenin in obese mice increased levels of NAD+ coenzyme, causing a global decrease in the acetylation of proteins, improving the homeostasis of glucose and lipids [55]. Also, the use of apigenin against colon cancer shows a time- and dose-dependent cell cycle arrest in the G2/M phase in colon carcinoma cell lines [35].
Genistein: Obtained from soy-based foods, genistein is a phytoestrogen compound that can bind to estrogen receptors [56][57]. Besides cancer treatment, biological potential in cognitive function has also been studied in cardiovascular and skeletal health. Genistein has neuroprotective and memory-enhancing effects. Its potential is attributed to antioxidant, anti-inflammatory, and cholinesterase inhibitory activities. Genistein helps treat breast cancer due to its estrogen receptor antagonist activity, induces apoptosis, and promotes synergistic inhibitory effects when combined with anticancer drugs [57].

References

  1. Di Renzo, L.; Gualtieri, P.; Romano, L.; Marrone, G.; Noce, A.; Pujia, A.; Perrone, M.A.; Aiello, V.; Colica, C.; De Lorenzo, A. Role of Personalized Nutrition in Chronic-Degenerative Diseases. Nutrients 2019, 11, 1707.
  2. Goldstein, D.S. How does homeostasis happen? Integrative physiological, systems biological, and evolutionary perspectives. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2019, 316, R301–R317.
  3. WHO. Health Systems and Health Security: Developing Conceptual Clarity and a WHO Roadmap for Action; World Health Organization, Ed.; World Health Organization: Geneva, Switzerland, 2018.
  4. Hosker, D.K.; Elkins, R.M.; Potter, M.P. Promoting Mental Health and Wellness in Youth Through Physical Activity, Nutrition, and Sleep. Child Adolesc. Psychiatr. Clin. N. Am. 2019, 28, 171–193.
  5. de Ridder, D.; Kroese, F.; Evers, C.; Adriaanse, M.; Gillebaart, M. Healthy diet: Health impact, prevalence, correlates, and interventions. Psychol. Health 2017, 32, 907–941.
  6. Córdova-Villalobos, J.Á.; Barriguete-Meléndez, J.A.; Lara-Esqueda, A.; Barquera, S.; Rosas-Peralta, M.; Hernández-Ávila, M.; de León-May, M.E.; Admon, L.; Aguilar-Salinas, C.A. Las enfermedades crónicas no transmisibles en México: Sinopsis epidemiológica y prevención integral. Salud Pública México 2008, 50, 419–427.
  7. Raiten, D.J.; Sakr Ashour, F.A.; Ross, A.C.; Meydani, S.N.; Dawson, H.D.; Stephensen, C.B.; Brabin, B.J.; Suchdev, P.S.; van Ommen, B. Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE). J. Nutr. 2015, 145, 1039S–1108S.
  8. World Health Organization. Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE); World Health Organization, Ed.; World Health Organization: Geneva, Switzerland, 2006.
  9. Sahib, N.G.; Anwar, F.; Gilani, A.-H.; Hamid, A.A.; Saari, N.; Alkharfy, K.M. Coriander (Coriandrum sativum L.): A potential source of high-value components for functional foods and nutraceuticals—A review. Phytother. Res. 2013, 27, 18.
  10. Perussello, C.A.; Zhang, Z.; Marzocchella, A.; Tiwari, B.K. Valorization of Apple Pomace by Extraction of Valuable Compounds. Compr. Rev. Food Sci. Food Saf. 2017, 16, 776–796.
  11. Sachdeva, V.; Roy, A.; Bharadvaja, N. Current Prospects of Nutraceuticals: A Review. Curr. Pharm. Biotechnol. 2020, 21, 884–896.
  12. Kalra, E.K. Nutraceutical—Definition and introduction. AAPS PharmSci. 2003, 5, E25.
  13. Bigiani, A. Electrophysiology of sodium receptors in taste cells. J. Biomed. Sci. Eng. 2016, 9, 367–383.
  14. Berdigaliyev, N.; Aljofan, M. An overview of drug discovery and development. Future Med. Chem. 2020, 12, 939–947.
  15. Zhang, R.; Monsma, F. Binding kinetics and mechanism of action: Toward the discovery and development of better and best in class drugs. Expert. Opin. Drug Discov. 2010, 5, 1023–1029.
  16. Fung, F.; Wang, H.S.; Menon, S. Food safety in the 21st century. Biomed. J. 2018, 41, 88–95.
  17. Arif, T. Salicylic acid as a peeling agent: A comprehensive review. Clin. Cosmet. Investig. Dermatol. 2015, 8, 455–461.
  18. Vane, J.R.; Botting, R.M. The mechanism of action of aspirin. Thromb. Res. 2003, 110, 255–258.
  19. McClements, D.J.; Li, F.; Xiao, H. The Nutraceutical Bioavailability Classification Scheme: Classifying Nutraceuticals According to Factors Limiting their Oral Bioavailability. Annu. Rev. Food Sci. Technol. 2015, 6, 299–327.
  20. Gul, K.; Singh, A.K.; Jabeen, R. Nutraceuticals and Functional Foods: The Foods for the Future World. Crit. Rev. Food Sci. Nutr. 2016, 56, 2617–2627.
  21. Gupta, R.C.; Srivastava, A.; Lall, R. Toxicity Potential of Nutraceuticals. Methods Mol. Biol. 2018, 1800, 367–394.
  22. Joyce, S.A.; Kamil, A.; Fleige, L.; Gahan, C.G.M. The Cholesterol-Lowering Effect of Oats and Oat Beta Glucan: Modes of Action and Potential Role of Bile Acids and the Microbiome. Front. Nutr. 2019, 6, 171.
  23. Gvozdjáková, A.; Pella, D.; Kucharská, J.; Otsuka, K.; Singh, R.B. Omega-3-PUFA, Omega-6-PUFA and Mitochondria. In Mitochondrial Medicine: Mitochondrial Metabolism, Diseases, Diagnosis and Therapy; Gvozdjáková, A., Ed.; Springer Netherlands: Dordrecht, The Netherlands, 2008; pp. 343–356.
  24. Dosedel, M.; Jirkovsky, E.; Macakova, K.; Krcmova, L.K.; Javorska, L.; Pourova, J.; Mercolini, L.; Remiao, F.; Novakova, L.; Mladenka, P.; et al. Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination. Nutrients 2021, 13, 615.
  25. Staufenbiel, I.; Weinspach, K.; Förster, G.; Geurtsen, W.; Günay, H. Periodontal conditions in vegetarians: A clinical study. Eur J. Clin. Nutr. 2013, 67, 5.
  26. Carr, A.C.; McCall, C. The role of vitamin C in the treatment of pain: New insights. J. Transl Med. 2017, 15, 77.
  27. Wacker, M.; Holick, M.F. Sunlight and Vitamin D: A global perspective for health. Dermato-Endocrinology 2013, 5, 51–108.
  28. Raederstorff, D.; Wyss, A.; Calder, P.C.; Weber, P.; Eggersdorfer, M. Vitamin E function and requirements in relation to PUFA. Br. J. Nutr. 2015, 114, 1113–1122.
  29. Abdelhamid, L.; Luo, X.M. Retinoic Acid, Leaky Gut, and Autoimmune Diseases. Nutrients 2018, 10, 1016.
  30. Kieliszek, M. Selenium(-)Fascinating Microelement, Properties and Sources in Food. Molecules 2019, 24, 1298.
  31. Frassinetti, S.; Bronzetti, G.; Caltavuturo, L.; Cini, M.; Croce, C.D. The role of zinc in life: A review. J. Environ. Pathol. Toxicol. Oncol. 2006, 25, 597–610.
  32. Del Ben, M.; Polimeni, L.; Baratta, F.; Pastori, D.; Angelico, F. The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease. Br. J. Clin. Pharmacol. 2017, 83, 88–95.
  33. Liu, C.H.; Jassey, A.; Hsu, H.Y.; Lin, L.T. Antiviral Activities of Silymarin and Derivatives. Molecules 2019, 24, 1552.
  34. Yang, K.; Chan, C.B. Epicatechin potentiation of glucose-stimulated insulin secretion in INS-1 cells is not dependent on its antioxidant activity. Acta Pharmacol. Sin. 2018, 39, 893–902.
  35. Shay, J.; Elbaz, H.A.; Lee, I.; Zielske, S.P.; Malek, M.H.; Huttemann, M. Molecular Mechanisms and Therapeutic Effects of (-)-Epicatechin and Other Polyphenols in Cancer, Inflammation, Diabetes, and Neurodegeneration. Oxid. Med. Cell Longev. 2015, 2015, 181260.
  36. Dower, J.I.; Geleijnse, J.M.; Gijsbers, L.; Zock, P.L.; Kromhout, D.; Hollman, P.C. Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: A randomized, double-blind, placebo-controlled, crossover trial. Am. J. Clin. Nutr. 2015, 101, 914–921.
  37. Xu, X.Y.; Meng, X.; Li, S.; Gan, R.Y.; Li, Y.; Li, H.B. Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives. Nutrients 2018, 10, 1553.
  38. Kunnumakkara, A.B.; Bordoloi, D.; Padmavathi, G.; Monisha, J.; Roy, N.K.; Prasad, S.; Aggarwal, B.B. Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. Br. J. Pharmacol. 2017, 174, 1325–1348.
  39. Farzaei, M.H.; Zobeiri, M.; Parvizi, F.; El-Senduny, F.F.; Marmouzi, I.; Coy-Barrera, E.; Naseri, R.; Nabavi, S.M.; Rahimi, R.; Abdollahi, M. Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective. Nutrients 2018, 10, 855.
  40. Chaplin, A.; Carpene, C.; Mercader, J. Resveratrol, Metabolic Syndrome, and Gut Microbiota. Nutrients 2018, 10, 1651.
  41. Gomes, B.A.Q.; Silva, J.P.B.; Romeiro, C.F.R.; Dos Santos, S.M.; Rodrigues, C.A.; Goncalves, P.R.; Sakai, J.T.; Mendes, P.F.S.; Varela, E.L.P.; Monteiro, M.C. Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1. Oxid. Med. Cell Longev. 2018, 2018, 8152373.
  42. Ko, J.H.; Sethi, G.; Um, J.Y.; Shanmugam, M.K.; Arfuso, F.; Kumar, A.P.; Bishayee, A.; Ahn, K.S. The Role of Resveratrol in Cancer Therapy. Int. J. Mol. Sci. 2017, 18, 2589.
  43. Cheng, Y.; Zhao, K.; Li, G.; Yao, J.; Dai, Q.; Hui, H.; Li, Z.; Guo, Q.; Lu, N. Oroxylin A inhibits hypoxia-induced invasion and migration of MCF-7 cells by suppressing the Notch pathway. Anticancer Drugs 2014, 25, 778–789.
  44. Zhao, K.; Zhou, Y.; Qiao, C.; Ni, T.; Li, Z.; Wang, X.; Guo, Q.; Lu, N.; Wei, L. Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells. J. Hematol. Oncol. 2015, 8, 41.
  45. Kwon, B.E.; Song, J.H.; Song, H.H.; Kang, J.W.; Hwang, S.N.; Rhee, K.J.; Shim, A.; Hong, E.H.; Kim, Y.J.; Jeon, S.M.; et al. Antiviral Activity of Oroxylin A against Coxsackievirus B3 Alleviates Virus-Induced Acute Pancreatic Damage in Mice. PLoS ONE 2016, 11, e0155784.
  46. Lee, A.Y.; Kang, S.; Park, S.J.; Huang, J.; Im, D.S. Anti-Allergic Effect of Oroxylin A from Oroxylum indicum Using in vivo and in vitro Experiments. Biomol. Ther. 2016, 24, 283–290.
  47. Jeon, S.J.; Bak, H.; Seo, J.; Han, S.M.; Lee, S.H.; Han, S.H.; Kwon, K.J.; Ryu, J.H.; Cheong, J.H.; Ko, K.H.; et al. Oroxylin A Induces BDNF Expression on Cortical Neurons through Adenosine A2A Receptor Stimulation: A Possible Role in Neuroprotection. Biomol. Ther. 2012, 20, 27–35.
  48. Zhou, W.; Liu, X.; Zhang, X.; Tang, J.; Li, Z.; Wang, Q.; Hu, R. Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome. Oncotarget 2017, 8, 58903–58917.
  49. Mlcek, J.; Jurikova, T.; Skrovankova, S.; Sochor, J. Quercetin and Its Anti-Allergic Immune Response. Molecules 2016, 21, 623.
  50. Egert, S.; Bosy-Westphal, A.; Seiberl, J.; Kurbitz, C.; Settler, U.; Plachta-Danielzik, S.; Wagner, A.E.; Frank, J.; Schrezenmeir, J.; Rimbach, G.; et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study. Br. J. Nutr. 2009, 102, 1065–1074.
  51. Ay, M.; Luo, J.; Langley, M.; Jin, H.; Anantharam, V.; Kanthasamy, A.; Kanthasamy, A.G. Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson’s Disease. J. Neurochem. 2017, 141, 766–782.
  52. Wu, C.C.; Fang, C.Y.; Cheng, Y.J.; Hsu, H.Y.; Chou, S.P.; Huang, S.Y.; Tsai, C.H.; Chen, J.Y. Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin. J. Biomed. Sci. 2017, 24, 2.
  53. Balez, R.; Steiner, N.; Engel, M.; Munoz, S.S.; Lum, J.S.; Wu, Y.; Wang, D.; Vallotton, P.; Sachdev, P.; O’Connor, M.; et al. Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease. Sci. Rep. 2016, 6, 31450.
  54. Gentile, D.; Fornai, M.; Colucci, R.; Pellegrini, C.; Tirotta, E.; Benvenuti, L.; Segnani, C.; Ippolito, C.; Duranti, E.; Virdis, A.; et al. The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity. PLoS ONE 2018, 13, e0195502.
  55. Escande, C.; Nin, V.; Price, N.L.; Capellini, V.; Gomes, A.P.; Barbosa, M.T.; O’Neil, L.; White, T.A.; Sinclair, D.A.; Chini, E.N. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes 2013, 62, 1084–1093.
  56. Menze, E.T.; Esmat, A.; Tadros, M.G.; Abdel-Naim, A.B.; Khalifa, A.E. Genistein improves 3-NPA-induced memory impairment in ovariectomized rats: Impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties. PLoS ONE 2015, 10, e0117223.
  57. Spagnuolo, C.; Russo, G.L.; Orhan, I.E.; Habtemariam, S.; Daglia, M.; Sureda, A.; Nabavi, S.F.; Devi, K.P.; Loizzo, M.R.; Tundis, R.; et al. Genistein and cancer: Current status, challenges, and future directions. Adv. Nutr. 2015, 6, 408–419.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Food Science & Technology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Aurora Garza-Juárez
,
Esther Pérez-Carrillo
,
Eder Ubaldo Arredondo-Espinoza
,
Jose Francisco Islas
,
Diego Francisco Benítez-Chao
,
Erandi Escamilla-García
View Times: 142
Revisions: 2 times (View History)
Update Date: 07 Sep 2023
Table of Contents
    1000/1000
    Hot Most Recent
    ScholarVision Creations
    Feedback